| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 1997N-0484T
|
| Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC1
|
|
|
|
|
| Submitter :
|
| Miss. DAWN Hunt
|
| Date & Time:
|
| 08/03/2005 02:08:02
|
|
|
|
|
| Organization :
|
| Fertility Alternatives, Inc
|
|
|
|
|
| Category :
|
| Other Organization
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| There is no indication in your documents with regards to curable infectious diseases for tissue donors, such as Chlamydia (for oocyte donors). If a donor tests positive for a bacterial infection that can be cured by antibiotics, it should state that donors can qualify after treatment and they retest negative.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|